Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -9.82 | 34.10 |
| PEG Ratio (TTM) | -1.00 | 3.75 |
| P/S Ratio (TTM) | 0.52 | 3.00 |
| P/B Ratio (TTM) | -2.23 | 6.91 |
| P/FCF Ratio (TTM) | 66.32 | 33.70 |
| Price to 5YR AVG Earnings Ratio | -8.69 | 80.37 |
| Price to 5YR AVG FCF Ratio | -60.01 | 603.82 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -18.25% | 8.30% |
| ROE (TTM) | 22.80% | 19.16% |
| Net Profit Margin (TTM) | -5.27% | 7.96% |
| ROIC 5YR AVG | -131.33% | 28.25% |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -51.35% | -45.64% | -197.05% |
| Revenue | 0.12% | 28.84% | 14.78% |
| Net Income | -55.14% | -49.12% | -203.76% |
| Cash Flow | 18.66% | 138.94% | 60.84% |
Health (12%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.83 | 1.24 |
| Quick Ratio (TTM) | 0.79 | 1.02 |
| D/E Ratio (TTM) | -1.16 | 0.31 |
| Interest Coverage (TTM) | -30.24 | 9.40 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 1.60 | 4.84 |
| LTL to 5YR AVG FCF | -29.77 | 42.23 |
| Shares Outstanding Growth 5YR AVG | 5.00% | 8.58% |